A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy-Reference-Cited by-同舟云学术

A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy

Published:2015-04 Issue:4 Volume:67 Page:778-786
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Klein Eric A.,Yousefi Kasra,Haddad Zaid,Choeurng Voleak,Buerki Christine,Stephenson Andrew J.,Li Jianbo,Kattan Michael W.,Magi-Galluzzi Cristina,Davicioni Elai

Publisher

Elsevier BV

Subject

Urology

Reference43 articles.

1. Predicting 15-year prostate cancer specific mortality after radical prostatectomy;Eggener;J Urol,2011

2. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794;Swanson;J Clin Oncol,2007

3. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary;Mullins;J Urol,2012

4. 2229 Comparison of clinical and genomic models for prediction of rapid metastatic disease after radical prostatectomy;Ross;J Urol,2013

5. Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer;Fraser;Urol Oncol,2014

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting;European Urology Oncology;2024-08

2. Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study;JCO Precision Oncology;2024-07

3. Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers;JCO Precision Oncology;2024-02

4. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11

5. Genomic classifiers and prognosis of localized prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-01-10